Thomas Woiwode is Director of Gritstone bio, Inc.. Currently has a direct ownership of 128 shares of GRTS, which is worth approximately $70. The most recent transaction as insider was on Aug 25, 2021, when has been sold 128 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128
0% 3M change
0% 12M change
Total Value Held $70

Thomas Woiwode Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 25 2021
BUY
Other acquisition or disposition
-
128 Added 50.0%
128 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
ADVM
Adverum Biotechnologies, Inc. Healthcare
PASG
Passage BIO, Inc. Healthcare
TPST
Tempest Therapeutics, Inc. Healthcare
TW

Thomas Woiwode

Director
Cambridge, MA

Track Institutional and Insider Activities on GRTS

Follow Gritstone bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRTS shares.

Notify only if

Insider Trading

Get notified when an Gritstone Bio, Inc. insider buys or sells GRTS shares.

Notify only if

News

Receive news related to Gritstone bio, Inc.

Track Activities on GRTS